This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medimmune Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Chris Stannard: Innovator in Antibody Technology
Introduction
Chris Stannard is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of biotechnology, particularly in the development of stabilized antibodies. His work focuses on innovative solutions that have the potential to impact medical treatments.
Latest Patents
Chris Stannard holds a patent for "Stabilized angiopoietin-2 antibodies and uses thereof." This patent describes stabilized antibodies directed to Angiopoietin-2 and outlines their various applications. The patent also includes nucleic acid and amino acid sequences, as well as hybridomas or other cell lines for expressing such antibodies.
Career Highlights
Stannard is currently associated with Medimmune Limited, a company known for its advancements in biopharmaceuticals. His role at Medimmune has allowed him to work on cutting-edge research and development projects that aim to improve therapeutic options for patients.
Collaborations
Throughout his career, Chris has collaborated with esteemed colleagues, including Vahe Bedian and William Dall'Acqua. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their field.
Conclusion
Chris Stannard's contributions to antibody technology exemplify the spirit of innovation in biotechnology. His patent and work at Medimmune Limited highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile